US Stock MarketDetailed Quotes
APLT Applied Therapeutics
- 2.030
- -6.540-76.31%
Close Nov 29 13:00 ET
- 2.110
- +0.080+3.94%
Post 17:02 ET
236.20MMarket Cap-1429P/E (TTM)
2.440High2.030Low43.90MVolume2.180Open8.570Pre Close96.65MTurnover51.96%Turnover RatioLossP/E (Static)116.36MShares10.62452wk High39.80P/B171.51MFloat Cap1.85052wk Low--Dividend TTM84.49MShs Float57.390Historical High--Div YieldTTM4.78%Amplitude0.500Historical Low2.201Avg Price1Lot Size
Applied Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -58.43%-23.33M | -37.34%-22.6M | -170.54%-18.91M | 29.35%-55.17M | -7.00%-17.01M | 24.05%-14.73M | 10.59%-16.45M | 71.36%-6.99M | 13.93%-78.09M | 41.01%-15.89M |
| Net income from continuing operations | -61.89%-68.59M | 109.80%2.9M | -728.04%-83.94M | -45.15%-119.76M | -161.13%-37.68M | -121.82%-42.37M | -14.39%-29.58M | 56.16%-10.14M | 21.86%-82.51M | 46.87%-14.43M |
| Operating gains losses | 47.33%40.19M | -277.64%-22.75M | 13,619.19%63.41M | 85,616.67%56.57M | 498.64%16.96M | 5,818.24%27.28M | 193.87%12.8M | -206.35%-469K | --66K | ---4.26M |
| Depreciation and amortization | -11.86%104K | 5.17%122K | 5.26%120K | -20.09%354K | -94.74%6K | 6.31%118K | 5.45%116K | 5.56%114K | 6.75%443K | 7.55%114K |
| Other non cash items | 13.22%-105K | 42.08%-512K | -59.94%260K | -44.58%1.74M | -39.55%2.1M | -9.01%-121K | 26.52%-884K | -34.25%649K | 878.96%3.15M | 3,408.57%3.47M |
| Change In working capital | 261.06%2.99M | -130.56%-4.81M | -242.48%-1.14M | 83.71%-1.44M | 15,381.82%1.7M | 52.35%-1.85M | -3,267.74%-2.09M | 116.28%798K | -1,340.39%-8.84M | 100.29%11K |
| -Change in prepaid assets | -67.91%-361K | -1,301.23%-1.14M | -73.37%-319K | 421.45%1.87M | 278.74%2.35M | -182.06%-215K | -108.89%-81K | 87.18%-184K | 121.70%359K | 213.53%621K |
| -Change in payables and accrued expense | 295.96%3.35M | -570.13%-3.68M | -106.47%-59K | 68.58%-2.06M | 33.24%-717K | 58.87%-1.71M | -125.75%-549K | 126.31%912K | -219.85%-6.56M | 66.48%-1.07M |
| -Change in other current liabilities | --0 | --0 | -1,184.29%-759K | -36.42%295K | -85.34%68K | --69K | --88K | --70K | --464K | --464K |
| -Change in other working capital | ---- | ---- | ---- | 50.21%-1.55M | --0 | --0 | ---- | ---- | 29.99%-3.11M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -58.43%-23.33M | -37.34%-22.6M | -170.54%-18.91M | 29.35%-55.17M | -7.00%-17.01M | 24.05%-14.73M | 10.59%-16.45M | 71.36%-6.99M | 13.93%-78.09M | 41.01%-15.89M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 5.33%13.87M | 0 | 0 | 0 | 45.64%13.87M | 5.93%13.17M | -158.48%-6.91M |
| Net investment purchase and sale | --0 | --0 | --0 | 5.33%13.87M | --0 | --0 | --0 | 45.64%13.87M | 5.93%13.17M | -158.48%-6.91M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | 5.33%13.87M | --0 | --0 | --0 | 45.64%13.87M | 5.93%13.17M | -158.48%-6.91M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -105.80%-1.69M | 18,668.65%115.5M | 169.18%74.54M | 3,256.06%29.45M | 1,806.18%16.57M | -4.06%29.15M | 21.17%-622K | -62.94%27.69M | 21.20%-933K |
| Net issuance payments of debt | --0 | --0 | 50.00%-311K | 43.23%-1.86M | 50.16%-465K | 50.11%-465K | 50.57%-306K | 21.17%-622K | 30.63%-3.27M | 21.20%-933K |
| Net common stock issuance | --0 | -107.18%-2M | --106.75M | 131.97%64.51M | --29.91M | 7,731.82%6.72M | --27.89M | --0 | -62.63%27.81M | --0 |
| Proceeds from stock option exercised by employees | --0 | 1,376.19%310K | --9.06M | 21,002.04%10.34M | --3K | 20,953.06%10.32M | --21K | --0 | -91.55%49K | --0 |
| Net other financing activities | ---- | ---- | ---- | -50.21%1.55M | --0 | --0 | ---- | ---- | -29.97%3.11M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -105.80%-1.69M | 18,668.65%115.5M | 169.18%74.54M | 3,256.06%29.45M | 1,806.18%16.57M | -4.06%29.15M | 21.17%-622K | -62.94%27.69M | 21.20%-933K |
| Net cash flow | ||||||||||
| Beginning cash position | 243.10%122.2M | 539.19%146.48M | 199.56%49.9M | -69.09%16.66M | -7.26%37.46M | -36.09%35.62M | -40.03%22.92M | -69.09%16.66M | -6.23%53.89M | -42.47%40.39M |
| Current changes in cash | -1,367.25%-23.33M | -291.25%-24.29M | 1,442.91%96.59M | 189.28%33.24M | 152.43%12.44M | 112.00%1.84M | -27.49%12.7M | 139.94%6.26M | -940.55%-37.23M | -45.42%-23.73M |
| End cash Position | 163.95%98.87M | 243.10%122.2M | 539.19%146.48M | 199.56%49.9M | 199.56%49.9M | -7.26%37.46M | -36.09%35.62M | -40.03%22.92M | -69.09%16.66M | -69.09%16.66M |
| Free cash flow | -58.43%-23.33M | -37.34%-22.6M | -170.54%-18.91M | 29.35%-55.17M | -7.00%-17.01M | 24.05%-14.73M | 10.59%-16.45M | 71.36%-6.99M | 13.93%-78.09M | 41.01%-15.89M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data